Synairgen plc Director/PDMR Shareholding (2402C)
October 15 2020 - 8:51AM
UK Regulatory
TIDMSNG
RNS Number : 2402C
Synairgen plc
15 October 2020
Synairgen plc
("Synairgen" or the "Company")
Director Dealing/PDMR Announcement
Further to the announcement earlier today regarding the Placing,
the Company makes the below announcement and notification in
accordance with the EU Market Abuse Regulation (No 596/2014) in
respect of the exercise of options by Richard Marsden, CEO of the
Company, and John Ward, Finance Director of the Company.
Enquiries:
Synairgen plc
+44 (0) 23 8051 2800
Richard Marsden (Chief Executive Officer)
John Ward (Finance Director)
finnCap - Nominated Adviser and Joint Bookrunner +44 (0) 20 7220
0500
Geoff Nash / James Thompson / Charlie Beeson (Corporate
Finance)
Alice Lane / Sunila de Silva (ECM)
Numis - Joint Bookrunner +44 (0) 20 7260 1000
James Black / Freddie Barnfield / Duncan Monteith
Consilium Strategic Communications - Financial Media and Investor +44 (0) 20 3709 5700
Relations Adviser
Mary-Jane Elliott / Sue Stuart / Olivia Manser
About Synairgen
Synairgen is a respiratory drug discovery and development
company founded by University of Southampton Professors Sir Stephen
Holgate, Donna Davies and Ratko Djukanovic. The business, focused
primarily on lung viral defence in asthma, COPD and COVID-19, uses
its differentiating human biology BioBank platform and
world-renowned international academic KOL network to discover and
develop novel therapies for respiratory disease. Synairgen is
quoted on AIM (LSE: SNG). For more information about Synairgen,
please see www.synairgen.com
1. Details of Persons Discharging Managerial Responsibilities ('PDMR')
/ person closely associated with them ('PCA')
a) Name R ichard Marsden
2. Reason for notification
a) Position / status Chief Executive Officer
b) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Synairgen plc
b) LEI 213800IMMTOPPDF8HD24
4. Details of the transaction(s):
a) Description of the financial O ptions over o rdinary shares of 1p each
instrument
Identification code GB00B0381Z20
b) Nature of the transaction Exercise of options over Ordinary Shares
c) Price(s) and volume(s) 386,842 Ordinary shares of 1p each
d) Aggregated information n/a
Aggregated volume Price
e) Date of the transaction 15 October 2020
f) Place of the transaction London Stock Exchange
1. Details of Persons Discharging Managerial Responsibilities ('PDMR')
/ person closely associated with them ('PCA')
a) Name John Ward
2. Reason for notification
a) Position / status Finance Director
b) Initial notification / amendment Initial Notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Synairgen plc
b) LEI 213800IMMTOPPDF8HD24
4. Details of the transaction(s):
a) Description of the financial instrument O ptions over o rdinary shares of 1p each
Identification code
GB00B0381Z20
b) Nature of the transaction Exercise of options over Ordinary Shares
c) Price(s) and volume(s) 147,330 Ordinary shares of 1p each
d) Aggregated information n/a
Aggregated volume Price
e) Date of the transaction 15 October 2020
f) Place of the transaction London Stock Exchange
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAAESFLNEFFA
(END) Dow Jones Newswires
October 15, 2020 08:51 ET (12:51 GMT)
Synairgen (LSE:SNG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synairgen (LSE:SNG)
Historical Stock Chart
From Apr 2023 to Apr 2024